By Paul Fassa
Source: COPD: Another Lucrative Big Pharma Fail For more content like this visit REALfarmacy.com.
by PAUL FASSA Medical costs for chronic obstructive pulmonary disease (COPD) in the United States are more than $32 billion each year, according to new research from the U.S. Centers for Disease Control and Prevention. The yearly financial toll of COPD is expected to reach an estimated $49 billion by 2020. [1] BIG PHARMA [&hellip
Source: COPD: Another Lucrative Big Pharma Fail Learn more at REALfarmacy.com – Healthy News and Information.
Read more here: realfarmacy.com
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr